Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RegeneSpine, also known as the Regenerative Spine and Joint Institute, is a specialized medical practice and research-oriented healthcare provider focused on interventional orthobiologics and pain management. Founded in 2013 by Dr. Stephen J. Roman, Jr., the institute provides non-surgical, minimally invasive treatments for chronic spine and joint conditions, including degenerative disc disease, osteoarthritis, and radiculopathy. Its core therapeutic offerings include the patented Discseel Procedure, Platelet Rich Plasma (PRP) therapy, and adipose-derived stem cell treatments. RegeneSpine operates multiple clinical locations across New Jersey and New York, collaborating with a network of neurosurgeons and specialists to deliver advanced regenerative care. The institute is also active in clinical research and the development of novel medical devices, such as specialized needle designs for cellular products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RegeneSpine.